StockWatch
·

Orchid Pharma Ltd Q4 FY25 Results

ORCHPHARMAQ4 FY25 Results
Filing
MetricValue ( Cr)vs Q3 FY25
Revenue237.489.3%
Total Income241.386.9%
Expenditure222.289.3%
PBT19.0914.9%
Net Profit22.297.3%
OPM11.78%11.06pp
NPM9.24%0.70pp
EPS4.407.3%
View full financials

Informational and educational content only. Not investment advice.